{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T19:12:51Z","timestamp":1792523571317,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007270","name":"University of Michigan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007270","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["euoncology.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Oncology"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.euo.2021.03.002","type":"journal-article","created":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T03:51:17Z","timestamp":1617249077000},"page":"430-439","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Development of a Whole-urine, Multiplexed, Next-generation RNA-sequencing Assay for Early Detection of Aggressive Prostate Cancer"],"prefix":"10.1016","volume":"5","author":[{"given":"Andi K.","family":"Cani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Jen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javed","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingye","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumin","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivas","family":"Nallandhighal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel H.","family":"Hovelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanbo","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trinh","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas W.","family":"Eyrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Randy","family":"Vince","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey J.","family":"Tosoian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganesh S.","family":"Palapattu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd M.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John T.","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron M.","family":"Udager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arul M.","family":"Chinnaiyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott A.","family":"Tomlins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7461-7079","authenticated-orcid":false,"given":"Simpa S.","family":"Salami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euo.2021.03.002_bib0005","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1056\/NEJM198710083171501","article-title":"Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate","volume":"317","author":"Stamey","year":"1987","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.euo.2021.03.002_bib0010","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1001\/jama.2018.3712","article-title":"Prostate-specific antigen-based screening for prostate cancer: evidence report and systematic review for the US Preventive Services Task Force","volume":"319","author":"Fenton","year":"2018","journal-title":"JAMA"},{"issue":"1 Suppl","key":"10.1016\/j.euo.2021.03.002_bib0015","first-page":"S19","article-title":"A multi-institutional evaluation of active surveillance for low risk prostate cancer","volume":"189","author":"Eggener","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2021.03.002_bib0020","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1001\/jama.2014.17942","article-title":"Comparison of MR\/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer","volume":"313","author":"Siddiqui","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.euo.2021.03.002_bib0025","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/cncr.29874","article-title":"Prostate cancer detection with magnetic resonance-ultrasound fusion biopsy: the role of systematic and targeted biopsies","volume":"122","author":"Filson","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.euo.2021.03.002_bib0030","first-page":"1","article-title":"Biologic significance of magnetic resonance imaging invisibility in localized prostate cancer","volume":"3","author":"Salami","year":"2019","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.euo.2021.03.002_bib0035","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.eururo.2018.11.031","article-title":"Detection of individual prostate cancer foci via multiparametric magnetic resonance imaging","volume":"75","author":"Johnson","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2021.03.002_bib0040","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/S0090-4295(02)01958-1","article-title":"Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program","volume":"60","author":"Raaijmakers","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.euo.2021.03.002_bib0045","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1615\/CritRevOncog.v5.i2-3.90","article-title":"The tumor-promoting effect of wounding: a possible role for TGF-beta-induced stromal alterations","volume":"5","author":"Sieweke","year":"1994","journal-title":"Crit Rev Oncog"},{"key":"10.1016\/j.euo.2021.03.002_bib0050","doi-asserted-by":"crossref","first-page":"7278","DOI":"10.1158\/0008-5472.CAN-08-1842","article-title":"Acute wounds accelerate tumorigenesis by a T cell-dependent mechanism","volume":"68","author":"Stuelten","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.euo.2021.03.002_bib0055","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.eururo.2013.12.062","article-title":"Overdiagnosis and overtreatment of prostate cancer","volume":"65","author":"Loeb","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2021.03.002_bib0060","doi-asserted-by":"crossref","first-page":"7991","DOI":"10.1158\/0008-5472.CAN-07-2043","article-title":"Heterogeneity of TMPRSS2 gene rearrangements in multifocal prostate adenocarcinoma: molecular evidence for an independent group of diseases","volume":"67","author":"Mehra","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.euo.2021.03.002_bib0065","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/ng.3315","article-title":"Spatial genomic heterogeneity within localized, multifocal prostate cancer","volume":"47","author":"Boutros","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.euo.2021.03.002_bib0070","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1158\/1078-0432.CCR-16-1454","article-title":"Molecular profiling to determine clonality of serial magnetic resonance imaging\/ultrasound fusion biopsies from men on active surveillance for low-risk prostate cancer","volume":"23","author":"Palapattu","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.euo.2021.03.002_bib0075","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1373\/clinchem.2005.063289","article-title":"APTIMA PCA3 molecular urine test: development of a method to aid in the diagnosis of prostate cancer","volume":"52","author":"Groskopf","year":"2006","journal-title":"Clin Chem"},{"key":"10.1016\/j.euo.2021.03.002_bib0080","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.eururo.2016.04.012","article-title":"Detection of high-grade prostate cancer using a urinary molecular biomarker-based risk score","volume":"70","author":"Van Neste","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2021.03.002_bib0085","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1001\/jamaoncol.2016.0097","article-title":"A novel urine exosome gene expression assay to predict high-grade prostate cancer at initial biopsy","volume":"2","author":"McKiernan","year":"2016","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.euo.2021.03.002_bib0090","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1126\/science.1117679","article-title":"Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer","volume":"310","author":"Tomlins","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.euo.2021.03.002_bib0095","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.eururo.2015.04.039","article-title":"Urine TMPRSS2:ERG plus PCA3 for individualized prostate cancer risk assessment","volume":"70","author":"Tomlins","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2021.03.002_bib0100","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.cell.2015.10.025","article-title":"The molecular taxonomy of primary prostate cancer","volume":"163","author":"Cancer Genome Atlas Research Network","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.euo.2021.03.002_bib0105","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nature11125","article-title":"The mutational landscape of lethal castration-resistant prostate cancer","volume":"487","author":"Grasso","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.euo.2021.03.002_bib0110","first-page":"75","article-title":"Translating cancer genomes and transcriptomes for precision oncology","volume":"66","author":"Roychowdhury","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.euo.2021.03.002_bib0115","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.eururo.2015.04.008","article-title":"Genomic predictors of outcome in prostate cancer","volume":"68","author":"Bostrom","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2021.03.002_bib0120","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.123468","article-title":"Transcriptomic heterogeneity in multifocal prostate cancer","volume":"3","author":"Salami","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.euo.2021.03.002_bib0125","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.eururo.2018.06.047","article-title":"Targeted DNA and RNA sequencing of paired urothelial and squamous bladder cancers reveals discordant genomic and transcriptomic events and unique therapeutic implications","volume":"74","author":"Hovelson","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2021.03.002_bib0130","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.neo.2015.03.004","article-title":"Development and validation of a scalable next-generation sequencing system for assessing relevant somatic variants in solid tumors","volume":"17","author":"Hovelson","year":"2015","journal-title":"Neoplasia"},{"key":"10.1016\/j.euo.2021.03.002_bib0135","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1158\/1541-7786.MCR-14-0578","article-title":"Next-gen sequencing exposes frequent MED12 mutations and actionable therapeutic targets in phyllodes tumors","volume":"13","author":"Cani","year":"2015","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.euo.2021.03.002_bib0140","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/modpathol.2016.79","article-title":"Comprehensive genomic profiling of orbital and ocular adnexal lymphomas identifies frequent alterations in MYD88 and chromatin modifiers: new routes to targeted therapies","volume":"29","author":"Cani","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1016\/j.euo.2021.03.002_bib0145","doi-asserted-by":"crossref","first-page":"7989","DOI":"10.18632\/oncotarget.14008","article-title":"Next generation sequencing of vitreoretinal lymphomas from small-volume intraocular liquid biopsies: new routes to targeted therapies","volume":"8","author":"Cani","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.euo.2021.03.002_bib0150","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1158\/0008-5472.CAN-17-2686","article-title":"Comprehensive mutation and copy number profiling in archived circulating breast cancer tumor cells documents heterogeneous resistance mechanisms","volume":"78","author":"Paoletti","year":"2018","journal-title":"Cancer Res"},{"key":"10.1016\/j.euo.2021.03.002_bib0155","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1056\/NEJMoa1110000","article-title":"Germline mutations in HOXB13 and prostate-cancer risk","volume":"366","author":"Ewing","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.euo.2021.03.002_bib0160","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/PAS.0000000000000090","article-title":"HOXB13 G84E-related familial prostate cancers: a clinical, histologic, and molecular survey","volume":"38","author":"Smith","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.euo.2021.03.002_bib0165","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.neo.2018.09.001","article-title":"MiPanda: a resource for analyzing and visualizing next-generation sequencing transcriptomics data","volume":"20","author":"Niknafs","year":"2018","journal-title":"Neoplasia"},{"key":"10.1016\/j.euo.2021.03.002_bib0170","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1038\/ng.2771","article-title":"The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI\/SNF complex","volume":"45","author":"Prensner","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.euo.2021.03.002_bib0175","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1001\/jama.2018.0154","article-title":"Effect of a low-intensity PSA-based screening intervention on prostate cancer mortality: the CAP randomized clinical trial","volume":"319","author":"Martin","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.euo.2021.03.002_bib0180","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1200\/JCO.2009.24.1968","article-title":"Reducing unnecessary biopsy during prostate cancer screening using a four-kallikrein panel: an independent replication","volume":"28","author":"Vickers","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euo.2021.03.002_bib0185","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1515\/cclm-2015-0599","article-title":"Comparative analysis of prostate cancer specific biomarkers PCA3 and ERG in whole urine, urinary sediments and exosomes","volume":"54","author":"Hendriks","year":"2016","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.euo.2021.03.002_bib0190","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.eururo.2011.08.003","article-title":"Contemporary role of prostate cancer antigen 3 in the management of prostate cancer","volume":"60","author":"Auprich","year":"2011","journal-title":"Eur Urol"}],"container-title":["European Urology Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931121000468?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931121000468?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:47:45Z","timestamp":1762876065000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2588931121000468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S2588931121000468"],"URL":"https:\/\/doi.org\/10.1016\/j.euo.2021.03.002","relation":{},"ISSN":["2588-9311"],"issn-type":[{"value":"2588-9311","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a Whole-urine, Multiplexed, Next-generation RNA-sequencing Assay for Early Detection of Aggressive Prostate Cancer","name":"articletitle","label":"Article Title"},{"value":"European Urology Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euo.2021.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}